Neratinib and Capecitabine for Patients with HER2+ Breast Cancer Brain Metastases (BCBM)

Daniela Bota, MD of UC Irvine Health discusses the use of neratinib and capecitabine in patients with breast cancer brain metastases at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beac... Author: moasc Added: 08/03/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts